IBDEI0EE ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18181,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,18181,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,18182,0)
 ;;=N76.3^^53^755^129
 ;;^UTILITY(U,$J,358.3,18182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18182,1,3,0)
 ;;=3^Subacute and chronic vulvitis
 ;;^UTILITY(U,$J,358.3,18182,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,18182,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,18183,0)
 ;;=N76.1^^53^755^128
 ;;^UTILITY(U,$J,358.3,18183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18183,1,3,0)
 ;;=3^Subacute and chronic vaginitis
 ;;^UTILITY(U,$J,358.3,18183,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,18183,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,18184,0)
 ;;=B97.89^^53^755^147
 ;;^UTILITY(U,$J,358.3,18184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18184,1,3,0)
 ;;=3^Viral syndrome
 ;;^UTILITY(U,$J,358.3,18184,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,18184,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,18185,0)
 ;;=Z72.51^^53^755^46
 ;;^UTILITY(U,$J,358.3,18185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18185,1,3,0)
 ;;=3^High Risk Sexual Behaviors
 ;;^UTILITY(U,$J,358.3,18185,1,4,0)
 ;;=4^Z72.51
 ;;^UTILITY(U,$J,358.3,18185,2)
 ;;=^5063258
 ;;^UTILITY(U,$J,358.3,18186,0)
 ;;=B16.9^^53^755^36
 ;;^UTILITY(U,$J,358.3,18186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18186,1,3,0)
 ;;=3^Hepatitis B, acute
 ;;^UTILITY(U,$J,358.3,18186,1,4,0)
 ;;=4^B16.9
 ;;^UTILITY(U,$J,358.3,18186,2)
 ;;=^5000540
 ;;^UTILITY(U,$J,358.3,18187,0)
 ;;=B18.1^^53^755^37
 ;;^UTILITY(U,$J,358.3,18187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18187,1,3,0)
 ;;=3^Hepatitis B, chronic without coma
 ;;^UTILITY(U,$J,358.3,18187,1,4,0)
 ;;=4^B18.1
 ;;^UTILITY(U,$J,358.3,18187,2)
 ;;=^5000547
 ;;^UTILITY(U,$J,358.3,18188,0)
 ;;=B17.10^^53^755^39
 ;;^UTILITY(U,$J,358.3,18188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18188,1,3,0)
 ;;=3^Hepatitis C, acute
 ;;^UTILITY(U,$J,358.3,18188,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,18188,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,18189,0)
 ;;=B18.2^^53^755^40
 ;;^UTILITY(U,$J,358.3,18189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18189,1,3,0)
 ;;=3^Hepatitis C, chronic without coma
 ;;^UTILITY(U,$J,358.3,18189,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,18189,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,18190,0)
 ;;=J11.1^^53^755^54
 ;;^UTILITY(U,$J,358.3,18190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18190,1,3,0)
 ;;=3^Influenza
 ;;^UTILITY(U,$J,358.3,18190,1,4,0)
 ;;=4^J11.1
 ;;^UTILITY(U,$J,358.3,18190,2)
 ;;=^5008158
 ;;^UTILITY(U,$J,358.3,18191,0)
 ;;=A92.30^^53^755^149
 ;;^UTILITY(U,$J,358.3,18191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18191,1,3,0)
 ;;=3^West Nile
 ;;^UTILITY(U,$J,358.3,18191,1,4,0)
 ;;=4^A92.30
 ;;^UTILITY(U,$J,358.3,18191,2)
 ;;=^5000443
 ;;^UTILITY(U,$J,358.3,18192,0)
 ;;=A41.4^^53^755^110
 ;;^UTILITY(U,$J,358.3,18192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18192,1,3,0)
 ;;=3^Sepsis due to anaerobes
 ;;^UTILITY(U,$J,358.3,18192,1,4,0)
 ;;=4^A41.4
 ;;^UTILITY(U,$J,358.3,18192,2)
 ;;=^5000206
 ;;^UTILITY(U,$J,358.3,18193,0)
 ;;=Z16.30^^53^755^49
 ;;^UTILITY(U,$J,358.3,18193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18193,1,3,0)
 ;;=3^Infection with drug-resistant organism
 ;;^UTILITY(U,$J,358.3,18193,1,4,0)
 ;;=4^Z16.30
 ;;^UTILITY(U,$J,358.3,18193,2)
 ;;=^5062737
 ;;^UTILITY(U,$J,358.3,18194,0)
 ;;=B96.4^^53^755^104
 ;;^UTILITY(U,$J,358.3,18194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18194,1,3,0)
 ;;=3^Proteus spp. (other)
 ;;^UTILITY(U,$J,358.3,18194,1,4,0)
 ;;=4^B96.4
 ;;^UTILITY(U,$J,358.3,18194,2)
 ;;=^5000853
 ;;^UTILITY(U,$J,358.3,18195,0)
 ;;=B96.5^^53^755^105
 ;;^UTILITY(U,$J,358.3,18195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18195,1,3,0)
 ;;=3^Pseudomonas spp.(other)
 ;;^UTILITY(U,$J,358.3,18195,1,4,0)
 ;;=4^B96.5
 ;;^UTILITY(U,$J,358.3,18195,2)
 ;;=^5000854
 ;;^UTILITY(U,$J,358.3,18196,0)
 ;;=B95.8^^53^755^121
 ;;^UTILITY(U,$J,358.3,18196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18196,1,3,0)
 ;;=3^Staphylococcus aureus, methicillin-susceptible
 ;;^UTILITY(U,$J,358.3,18196,1,4,0)
 ;;=4^B95.8
 ;;^UTILITY(U,$J,358.3,18196,2)
 ;;=^5000844
 ;;^UTILITY(U,$J,358.3,18197,0)
 ;;=B95.61^^53^755^120
 ;;^UTILITY(U,$J,358.3,18197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18197,1,3,0)
 ;;=3^Staphylococcus aureus, methicillin-resistant
 ;;^UTILITY(U,$J,358.3,18197,1,4,0)
 ;;=4^B95.61
 ;;^UTILITY(U,$J,358.3,18197,2)
 ;;=^5000841
 ;;^UTILITY(U,$J,358.3,18198,0)
 ;;=B95.7^^53^755^122
 ;;^UTILITY(U,$J,358.3,18198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18198,1,3,0)
 ;;=3^Staphylococcus spp.(other)
 ;;^UTILITY(U,$J,358.3,18198,1,4,0)
 ;;=4^B95.7
 ;;^UTILITY(U,$J,358.3,18198,2)
 ;;=^5000843
 ;;^UTILITY(U,$J,358.3,18199,0)
 ;;=B95.0^^53^755^125
 ;;^UTILITY(U,$J,358.3,18199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18199,1,3,0)
 ;;=3^Streptococcus, Group A
 ;;^UTILITY(U,$J,358.3,18199,1,4,0)
 ;;=4^B95.0
 ;;^UTILITY(U,$J,358.3,18199,2)
 ;;=^5000835
 ;;^UTILITY(U,$J,358.3,18200,0)
 ;;=B95.1^^53^755^126
 ;;^UTILITY(U,$J,358.3,18200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18200,1,3,0)
 ;;=3^Streptococcus, Group B
 ;;^UTILITY(U,$J,358.3,18200,1,4,0)
 ;;=4^B95.1
 ;;^UTILITY(U,$J,358.3,18200,2)
 ;;=^5000836
 ;;^UTILITY(U,$J,358.3,18201,0)
 ;;=B95.3^^53^755^123
 ;;^UTILITY(U,$J,358.3,18201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18201,1,3,0)
 ;;=3^Streptococcus pneumoniae
 ;;^UTILITY(U,$J,358.3,18201,1,4,0)
 ;;=4^B95.3
 ;;^UTILITY(U,$J,358.3,18201,2)
 ;;=^5000838
 ;;^UTILITY(U,$J,358.3,18202,0)
 ;;=B95.4^^53^755^124
 ;;^UTILITY(U,$J,358.3,18202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18202,1,3,0)
 ;;=3^Streptococcus spp. (other)
 ;;^UTILITY(U,$J,358.3,18202,1,4,0)
 ;;=4^B95.4
 ;;^UTILITY(U,$J,358.3,18202,2)
 ;;=^5000839
 ;;^UTILITY(U,$J,358.3,18203,0)
 ;;=A02.0^^53^755^108
 ;;^UTILITY(U,$J,358.3,18203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18203,1,3,0)
 ;;=3^Salmonella enteritis
 ;;^UTILITY(U,$J,358.3,18203,1,4,0)
 ;;=4^A02.0
 ;;^UTILITY(U,$J,358.3,18203,2)
 ;;=^5000011
 ;;^UTILITY(U,$J,358.3,18204,0)
 ;;=A41.2^^53^755^111
 ;;^UTILITY(U,$J,358.3,18204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18204,1,3,0)
 ;;=3^Sepsis-Staphylococcus
 ;;^UTILITY(U,$J,358.3,18204,1,4,0)
 ;;=4^A41.2
 ;;^UTILITY(U,$J,358.3,18204,2)
 ;;=^5000204
 ;;^UTILITY(U,$J,358.3,18205,0)
 ;;=A41.52^^53^755^115
 ;;^UTILITY(U,$J,358.3,18205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18205,1,3,0)
 ;;=3^Septicemia-Pseudomonas
 ;;^UTILITY(U,$J,358.3,18205,1,4,0)
 ;;=4^A41.52
 ;;^UTILITY(U,$J,358.3,18205,2)
 ;;=^5000209
 ;;^UTILITY(U,$J,358.3,18206,0)
 ;;=A41.51^^53^755^113
 ;;^UTILITY(U,$J,358.3,18206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18206,1,3,0)
 ;;=3^Septicemia-E. coli
 ;;^UTILITY(U,$J,358.3,18206,1,4,0)
 ;;=4^A41.51
 ;;^UTILITY(U,$J,358.3,18206,2)
 ;;=^5000208
 ;;^UTILITY(U,$J,358.3,18207,0)
 ;;=A41.59^^53^755^114
 ;;^UTILITY(U,$J,358.3,18207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18207,1,3,0)
 ;;=3^Septicemia-Gram Negative Organisms NEC
 ;;^UTILITY(U,$J,358.3,18207,1,4,0)
 ;;=4^A41.59
 ;;^UTILITY(U,$J,358.3,18207,2)
 ;;=^5000211
 ;;^UTILITY(U,$J,358.3,18208,0)
 ;;=A53.9^^53^755^137
 ;;^UTILITY(U,$J,358.3,18208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18208,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,18208,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,18208,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,18209,0)
 ;;=B37.9^^53^755^22
 ;;^UTILITY(U,$J,358.3,18209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18209,1,3,0)
 ;;=3^Candidiasis,Unspec
 ;;^UTILITY(U,$J,358.3,18209,1,4,0)
 ;;=4^B37.9
 ;;^UTILITY(U,$J,358.3,18209,2)
 ;;=^5000624
 ;;^UTILITY(U,$J,358.3,18210,0)
 ;;=B46.9^^53^755^150
 ;;^UTILITY(U,$J,358.3,18210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18210,1,3,0)
 ;;=3^Zygomycosis, unspecified
 ;;^UTILITY(U,$J,358.3,18210,1,4,0)
 ;;=4^B46.9
 ;;^UTILITY(U,$J,358.3,18210,2)
 ;;=^5000683
 ;;^UTILITY(U,$J,358.3,18211,0)
 ;;=B59.^^53^755^94
 ;;^UTILITY(U,$J,358.3,18211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18211,1,3,0)
 ;;=3^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,18211,1,4,0)
 ;;=4^B59.
 ;;^UTILITY(U,$J,358.3,18211,2)
 ;;=^5000734
 ;;^UTILITY(U,$J,358.3,18212,0)
 ;;=B42.9^^53^755^119
 ;;^UTILITY(U,$J,358.3,18212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18212,1,3,0)
 ;;=3^Sporotrichosis, unspecified
 ;;^UTILITY(U,$J,358.3,18212,1,4,0)
 ;;=4^B42.9
 ;;^UTILITY(U,$J,358.3,18212,2)
 ;;=^5000657
 ;;^UTILITY(U,$J,358.3,18213,0)
 ;;=B36.9^^53^755^130
 ;;^UTILITY(U,$J,358.3,18213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18213,1,3,0)
 ;;=3^Superficial mycosis, unspecified
 ;;^UTILITY(U,$J,358.3,18213,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,18213,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,18214,0)
 ;;=B78.9^^53^755^127
 ;;^UTILITY(U,$J,358.3,18214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18214,1,3,0)
 ;;=3^Strongyloidiasis, unspecified
 ;;^UTILITY(U,$J,358.3,18214,1,4,0)
 ;;=4^B78.9
 ;;^UTILITY(U,$J,358.3,18214,2)
 ;;=^5000791
 ;;^UTILITY(U,$J,358.3,18215,0)
 ;;=B58.9^^53^755^139
 ;;^UTILITY(U,$J,358.3,18215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18215,1,3,0)
 ;;=3^Toxoplasmosis, unspecified
 ;;^UTILITY(U,$J,358.3,18215,1,4,0)
 ;;=4^B58.9
 ;;^UTILITY(U,$J,358.3,18215,2)
 ;;=^5000733
 ;;^UTILITY(U,$J,358.3,18216,0)
 ;;=M79.1^^53^755^74
 ;;^UTILITY(U,$J,358.3,18216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18216,1,3,0)
 ;;=3^Myalgia
 ;;^UTILITY(U,$J,358.3,18216,1,4,0)
 ;;=4^M79.1
 ;;^UTILITY(U,$J,358.3,18216,2)
 ;;=^5013321
 ;;^UTILITY(U,$J,358.3,18217,0)
 ;;=R76.11^^53^755^2
 ;;^UTILITY(U,$J,358.3,18217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18217,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,18217,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,18217,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,18218,0)
 ;;=A60.9^^53^755^3
 ;;^UTILITY(U,$J,358.3,18218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18218,1,3,0)
 ;;=3^Angenital Herpersviral Infection,Unspec
